Literature DB >> 27835622

Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring.

Jessica E Haberer1, Nicholas Musinguzi, Alexander C Tsai, Yap Boum, Bosco M Bwana, Conrad Muzoora, Peter W Hunt, Jeffrey N Martin, David R Bangsberg.   

Abstract

The impact of real-time electronic monitoring on antiretroviral therapy adherence warrants further study. We conducted an analysis of cohort participants that initially involved standard electronic adherence monitoring (EAM), followed by real-time EAM and home visits for sustained at least 48-h adherence interruptions. Immediately after switching between the two types of EAM, mean adherence among 112 participants increased from 84% to 93% and remained elevated for 6 months (P < 0.001). Real-time EAM is a promising approach for improving adherence.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27835622      PMCID： PMC5280076          DOI： 10.1097/QAD.0000000000001310

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  18 in total

1.  Assessment of depression prevalence in rural Uganda using symptom and function criteria.

Authors:  Paul Bolton; Christopher M Wilk; Lincoln Ndogoni
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-06       Impact factor: 4.328

2.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

3.  Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Richard E Chaisson; Leon Regensberg; Gary Maartens
Journal:  Ann Intern Med       Date:  2007-04-17       Impact factor: 25.391

4.  Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.

Authors:  Jessica E Haberer; Nicholas Musinguzi; Yap Boum; Mark J Siedner; A Rain Mocello; Peter W Hunt; Jeffrey N Martin; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

5.  Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda.

Authors:  Alexander C Tsai; David R Bangsberg; Edward A Frongillo; Peter W Hunt; Conrad Muzoora; Jeffrey N Martin; Sheri D Weiser
Journal:  Soc Sci Med       Date:  2012-03-23       Impact factor: 4.634

6.  Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.

Authors:  Jose R Castillo-Mancilla; Todd T Brown; Kristine M Erlandson; Frank J Palella; Edward M Gardner; Bernard J C Macatangay; Elizabeth C Breen; Lisa P Jacobson; Peter L Anderson; Nikolas I Wada
Journal:  Clin Infect Dis       Date:  2016-09-22       Impact factor: 9.079

7.  Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda.

Authors:  Susan A Adakun; Mark J Siedner; Conrad Muzoora; Jessica E Haberer; Alexander C Tsai; Peter W Hunt; Jeff N Martin; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Real-time adherence monitoring for HIV antiretroviral therapy.

Authors:  Jessica E Haberer; Josh Kahane; Isaac Kigozi; Nneka Emenyonu; Peter Hunt; Jeffrey Martin; David R Bangsberg
Journal:  AIDS Behav       Date:  2010-12

9.  A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.

Authors:  Catherine Orrell; Karen Cohen; Katya Mauff; David R Bangsberg; Gary Maartens; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

10.  Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.

Authors:  Nicholas Musinguzi; Rain A Mocello; Yap Boum; Peter W Hunt; Jeffrey N Martin; Jessica E Haberer; David R Bangsberg; Mark J Siedner
Journal:  AIDS Behav       Date:  2017-06
View more
  15 in total

1.  If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.

Authors:  Alissa Davis; Lyailya Sarsembayeva; Valeriy Gulyaev; Sholpan Primbetova; Assel Terlikbayeva; Gaukhar Mergenova; Robert H Remien
Journal:  AIDS Behav       Date:  2019-12

Review 2.  Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.

Authors:  Kate M Bell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-10       Impact factor: 5.071

3.  Dependence on Digital Medicine in Resource-Limited Settings.

Authors:  Jeffrey I Campbell; Jessica Haberer; Angella Musiimenta; Nir Eyal
Journal:  Am J Bioeth       Date:  2018-09       Impact factor: 11.229

Review 4.  Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.

Authors:  Matthew A Spinelli; Jessica E Haberer; Peter R Chai; Jose Castillo-Mancilla; Peter L Anderson; Monica Gandhi
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

5.  Retention in HIV Care Among HIV-Seropositive Pregnant and Postpartum Women in Uganda: Results of a Randomized Controlled Trial.

Authors:  Lora L Sabin; Nafisa Halim; Davidson H Hamer; Elizabeth M Simmons; Sivani Jonnalagadda; Anna Larson Williams; Harriet Chemusto; Allen L Gifford; Rachael Bonawitz; Philip Aroda; Mary DeSilva; Julia Gasuza; Barbara Mukasa; Lisa J Messersmith
Journal:  AIDS Behav       Date:  2020-11

Review 6.  Adolescent pre-exposure prophylaxis for HIV prevention: current perspectives.

Authors:  Daisy Maria Machado; Alexandre Machado de Sant'Anna Carvalho; Rachel Riera
Journal:  Adolesc Health Med Ther       Date:  2017-11-29

7.  Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis.

Authors:  Xiaoqiu Liu; Terrence Blaschke; Bruce Thomas; Sabina De Geest; Shiwen Jiang; Yongxin Gao; Xinxu Li; Elizabeth Whalley Buono; Stacy Buchanan; Zhiying Zhang; Shitong Huan
Journal:  Int J Environ Res Public Health       Date:  2017-09-25       Impact factor: 3.390

8.  Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.

Authors:  Rebecca Arden Harris; Jessica E Haberer; Nicholas Musinguzi; Kyong-Mi Chang; Clyde B Schechter; Chyke A Doubeni; Robert Gross
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

9.  Evaluation of the effect of cellular SMS reminders on consistency of antiretroviral therapy pharmacy pickups in HIV-infected adults in Botswana: a randomized controlled trial.

Authors:  Michael J A Reid; Andrew P Steenhoff; James Thompson; Lesego Gabaitiri; Mark S Cary; Katherine Steele; Susan Mayisela; Diana Dickinson; Peter Ehrenkranz; Harvey M Friedman; Darren R Linkin
Journal:  Health Psychol Behav Med       Date:  2017-01-09

10.  Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial.

Authors:  Angella Musiimenta; Esther C Atukunda; Wilson Tumuhimbise; Emily E Pisarski; Melanie Tam; Monique A Wyatt; Norma C Ware; Jessica E Haberer
Journal:  JMIR Mhealth Uhealth       Date:  2018-05-17       Impact factor: 4.773
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.